<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Friedreich's <z:hpo ids='HP_0001251'>ataxia</z:hpo> (FRDA) is the most common inherited human <z:hpo ids='HP_0001251'>ataxia</z:hpo> and is caused by a deficiency in the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> protein frataxin </plain></SENT>
<SENT sid="1" pm="."><plain>Clinically, patients suffer from progressive <z:hpo ids='HP_0002503'>spinocerebellar degeneration</z:hpo>, <z:mp ids='MP_0002055'>diabetes</z:mp> and a fatal <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>, associated with <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> respiratory chain defects </plain></SENT>
<SENT sid="2" pm="."><plain>Recent findings have shown that lysine acetylation regulates <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> function and intermediary metabolism </plain></SENT>
<SENT sid="3" pm="."><plain>However, little is known about lysine acetylation in the setting of pathologic energy stress and <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dysfunction </plain></SENT>
<SENT sid="4" pm="."><plain>We tested the hypothesis that the respiratory chain defects in frataxin deficiency alter <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> protein acetylation </plain></SENT>
<SENT sid="5" pm="."><plain>Using two conditional mouse models of FRDA, we demonstrate marked hyperacetylation of numerous cardiac <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> proteins </plain></SENT>
<SENT sid="6" pm="."><plain>Importantly, this biochemical phenotype develops concurrently with <z:mp ids='MP_0001625'>cardiac hypertrophy</z:mp> and is caused by inhibition of the <z:chebi fb="0" ids="15846">NAD(+)</z:chebi>-dependent SIRT3 deacetylase </plain></SENT>
<SENT sid="7" pm="."><plain>This inhibition is caused by an 85-fold decrease in <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> <z:chebi fb="0" ids="15846">NAD(+)</z:chebi>/<z:chebi fb="0" ids="16908">NADH</z:chebi> and direct <z:chebi fb="0" ids="23019">carbonyl group</z:chebi> modification of SIRT3, and is reversed with excess SIRT3 and <z:chebi fb="0" ids="15846">NAD(+)</z:chebi> in vitro </plain></SENT>
<SENT sid="8" pm="."><plain>We further demonstrate that protein hyperacetylation may be a common feature of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> disorders caused by respiratory chain defects, notably, <z:chebi fb="0" ids="4056">cytochrome</z:chebi> oxidase I (COI) deficiency </plain></SENT>
<SENT sid="9" pm="."><plain>These findings suggest that SIRT3 inhibition and consequent protein hyperacetylation represents a negative feedback mechanism limiting <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> oxidative pathways when respiratory metabolism is compromised, and thus, may contribute to the lethal <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> in FRDA </plain></SENT>
</text></document>